We serve 4-[(2-ethoxybenzoyl)amino]-2-methyl-5-propylpyrazole-3-carboxamide CAS:139756-03-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![4-[(2-ethoxybenzoyl)amino]-2-methyl-5-propylpyrazole-3-carboxamide](https://a.dearchem.com/uploads/userup/0/15M432548-H47.png)
Chemical Name:4-[(2-ethoxybenzoyl)amino]-2-methyl-5-propylpyrazole-3-carboxamide
CAS.NO: 139756-03-9
Synonyms:
4-[(2-Ethoxybenzoyl)amino]-1-methyl-3-propyl-1H-pyrazole-5-carboxamide
1H-Pyrazole-5-carboxamide, 4-[(2-ethoxybenzoyl)amino]-1-methyl-3-propyl-
4-(2-Ethoxybenzamido)-1-methyl-3-n-propylpyrazole-5-carboxamide
Molecular Formula: C17H22N4O3
Molecular Weight: 330.38200
Physical and Chemical Properties:
Density: 1.24g / cm3
Boiling point: 445.5ºC at 760 mmHg
Melting point: /
Flash point: 223.2ºC
Refractive index: 1.598
Specification:
Appearance:White Solid
Purity:≥98%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage:-20ºC Freezer.Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Sildenafil citrate CAS:171599-83-0
Intermediates of Rimsulfuron CAS:122931-48-0
Contact us for information like 4-[(2-ethoxybenzoyl)amino]-2-methyl-5-propylpyrazole-3-carboxamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-(2-Ethoxybenzamido)-1-methyl-3-n-propylpyrazole-5-carboxamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-[(2-Ethoxybenzoyl)amino]-1-methyl-3-propyl-1H-pyrazole-5-carboxamide Use and application,4-[(2-Ethoxybenzoyl)amino]-1-methyl-3-propyl-1H-pyrazole-5-carboxamide technical grade,usp/ep/jp grade.
Related News: Subsequently, the company launched the drug under the brand names ‘Remo’ and ‘Remozen’.3,4-Dimethoxyphenylboronic Acid manufacturer With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout.(2S)-5-methoxy-1,2,3,4-tetrahydronaphthalen-2-amine supplier With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout.2-Chloro-3-fluoro-4-methylpyridine vendor As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials.How does the virus spread? The virus is thought to spread from person to person through respiratory droplets emitted by coughing or sneezing — but it’s not clear exactly when a person becomes contagious. There’s currently no evidence that the virus is airborne — meaning, for instance, it doesn’t travel across a large room.
